Optimized Polyethylene Glycolylated Polymer-Lipid Hybrid Nanoparticles as a Potential Breast Cancer Treatment.
Salam MassadehMustafa E OmerAsmaa AlterawiRizwan AliFayez H AlanaziFares AlmutairiWejdan AlmotairiFaris F AlobaidiKhulud AlhelalMansour S AlmutairiAbdulaziz AlmalikAiman A ObaidatManal AlaameryAlaa Eldeen B YassinPublished in: Pharmaceutics (2020)
PEGylated polymeric nanoparticles presented a stable encapsulated system with which to incorporate an anticancer drug (ANS) with a high percentage of entrapment efficiency (around 80%), good size uniformity, and induction of apoptosis in MCF-7 cells.